Liege 2019 – Radiopharmacy Programme
It is our pleasure to anounce the preliminary Radiopharmacy Programme of the 2019 BELNUC Symposium that will be held in Liege on May 10-12
Saturday, May 11, 2019
8:40-8:50: WELCOME
9:00-10:30: OPPORTUNITIES FOR PATIENT CARE (common session)
Developments in total body PET/CT systems
Prof Dr Stefaan Vandenberghe, MEDISIP-ELIS-IBITECH-IMEC, Ghent University, Belgium
PSMA targeted radionuclide therapy
Dr Andrei Gafita, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany
Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases
Prof Dr Marnix Lam, Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands
11:00-12:00: RADIOCHEMISTRY
Gallium-68 produced by cyclotron vs generator: pros and cons
Dr Simon Lacroix, Nuclear Medicine Department, Hôpital Erasme, Brussels, Belgium
& Dr Zéna Wimana, Nuclear Medicine Department, Institut Jules Bordet, Brussels, Belgium
Scientific abstracts : OP 1-3
Abstract presenting authors
14:00-15:30: TARGET
How to investigate the radiobiological effects of radionuclide therapies: Models, techniques & tools
Prof Sarah Baatout, Radiobiology unit, SCK.CEN, Mol, Belgium
Scientific abstracts: OP 4-12
Abstract presenting authors
16:00-17:00: RADIOPHARMACY GMP/REGULATIONS
Pharmaceutical Quality System
Kim Serdons, Nuclear Medicine Departement, UZ Leuven, Leuven, Belgium
Scientific abstracts: OP 13-15
Abstract presenting authors
17:00-17:30: RADIONUCLIDE THERAPY (common session)
Nanobodies labeled with 225Ac for targeted α-particle therapy
Prof Matthias D’Huyvetter, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Belgium
17:30-18:00: BELNUC AWARDS CEREMONY
- FANC/AFCN Radiation protection continuing education credits: to be requested